{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:20:55Z","timestamp":1771323655722,"version":"3.50.1"},"reference-count":27,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Breathe"],"accepted":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Tuberculosis (TB) remains a major public health challenge, particularly in low- and middle-income countries (LMICs), with treatment adherence being a critical issue. In recent years, digital adherence technologies (DATs) have emerged as a promising approach to enhance TB care and treatment adherence in these settings. Despite their potential to enhance treatment outcomes, their implementation faces challenges, including infrastructure demands, costs, and variability in effectiveness depending on the context. A critical aspect of DATs is their cost-effectiveness, which has shown mixed results across different LMICs. Some technologies, such as the medication sleeves\/labels (\n                    <jats:italic>e.g.<\/jats:italic>\n                    , 99DOTS), demonstrate low-cost alternatives to traditional directly observed therapy (DOT), while others report inconsistent outcomes. Throughout its implementation, DATs can be a source of intervention-generated inequality, where they may disproportionately benefit low-risk populations with better access to technology, potentially widening gaps in healthcare equity. However, when targeted effectively at high-risk groups, DATs can promote equitable health outcomes and enhance TB care delivery. The successful implementation of DATs requires context-specific strategies that address the unique challenges of LMICs, such as technology fatigue, data privacy, and the need for tailored interventions that consider socioeconomic and cultural factors. Leveraging the support of global health initiatives and collaborative funding mechanisms could help scale up DAT adoption and contribute to the global goal of TB elimination.\n                  <\/jats:p>","DOI":"10.1183\/20734735.0173-2025","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:30:15Z","timestamp":1771320615000},"page":"250173","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing tuberculosis care in lower and middle-income countries through digital adherence technologies"],"prefix":"10.1183","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0648-6825","authenticated-orcid":false,"given":"Rabbyia","family":"Ahmad","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-6670","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ramos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-3099","authenticated-orcid":false,"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-4741","authenticated-orcid":false,"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[]},{"given":"Job","family":"Van Rest","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026021701300540000_22.1.250173.1","unstructured":"World Health Organization . Tuberculosis preventive treatment: rapid communication. Geneva, World Health Organization, 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240089723"},{"key":"2026021701300540000_22.1.250173.2","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1093\/cid\/ciaa333","article-title":"Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications: comparison of DigitalAdherence data with urine isoniazid testing","volume":"71","author":"Thomas","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026021701300540000_22.1.250173.3","doi-asserted-by":"crossref","first-page":"e1003899","DOI":"10.1371\/journal.pmed.1003899","article-title":"Integrating tuberculosis and noncommunicable diseases care in low-and middle-income countries (LMICs): a systematic review","volume":"19","author":"Foo","year":"2022","journal-title":"PLoS Med"},{"key":"2026021701300540000_22.1.250173.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00731-y"},{"key":"2026021701300540000_22.1.250173.5","first-page":"472","article-title":"Tuberculosis treatment","volume":"43","author":"Fouad Rabahi","year":"2017","journal-title":"Braz J Pulmonol"},{"key":"2026021701300540000_22.1.250173.6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5588\/ijtld.24.0587","article-title":"Implementation","volume":"29","author":"Crowder","year":"2025","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026021701300540000_22.1.250173.7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-pharmtox-041921-074800","article-title":"Emerging therapeutics, technologies, and drug development strategies to address patient nonadherence and improve tuberculosis treatment","volume":"62","author":"Garcia-Cremades","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026021701300540000_22.1.250173.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053373"},{"key":"2026021701300540000_22.1.250173.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08418-2"},{"key":"2026021701300540000_22.1.250173.10","doi-asserted-by":"publisher","DOI":"10.2196\/33062"},{"key":"2026021701300540000_22.1.250173.11","doi-asserted-by":"crossref","first-page":"e57991","DOI":"10.2196\/57991","article-title":"Effectiveness of a mobile health intervention (DOT selfie) in increasing treatment adherence monitoring and support for patients with tuberculosis in Uganda: randomized controlled trial","volume":"13","author":"Sekandi","year":"2025","journal-title":"JMIR Mhealth Uhealth"},{"key":"2026021701300540000_22.1.250173.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.09.029"},{"key":"2026021701300540000_22.1.250173.13","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1186\/s12889-023-16905-z","article-title":"Risk factors for poor engagement with a smart pillbox adherence intervention among persons on tuberculosis treatment in Ethiopia","volume":"23","author":"Tadesse","year":"2023","journal-title":"BMC Public Health"},{"key":"2026021701300540000_22.1.250173.14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1186\/s12879-024-09744-9","article-title":"Understanding the role of video direct observed therapy for patients on an oral short-course regimen for multi-drug resistant tuberculosis: findings from a qualitative study in Eswatini","volume":"24","author":"Mukooza","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2026021701300540000_22.1.250173.15","doi-asserted-by":"crossref","unstructured":"Cross A , Gupta N , Liu B , et al. 99DOTS: a low-cost approach to monitoring and improving medication adherence. In: Proceedings of the Tenth International Conference on Information and Communication Technologies and Development, 2019; pp. 1\u201312.","DOI":"10.1145\/3287098.3287102"},{"key":"2026021701300540000_22.1.250173.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001018"},{"key":"2026021701300540000_22.1.250173.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162944"},{"key":"2026021701300540000_22.1.250173.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003628"},{"key":"2026021701300540000_22.1.250173.19","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0373"},{"key":"2026021701300540000_22.1.250173.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065202"},{"key":"2026021701300540000_22.1.250173.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2024-015654"},{"key":"2026021701300540000_22.1.250173.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-068685"},{"key":"2026021701300540000_22.1.250173.23","doi-asserted-by":"crossref","first-page":"e0000322","DOI":"10.1371\/journal.pdig.0000322","article-title":"Acceptability and feasibility of digital adherence technologies for drug-susceptible tuberculosis treatment supervision: a meta-analysis of implementation feedback","volume":"2","author":"Guzman","year":"2023","journal-title":"PLoS Digit Health"},{"key":"2026021701300540000_22.1.250173.24","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocy052"},{"key":"2026021701300540000_22.1.250173.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-010512"},{"key":"2026021701300540000_22.1.250173.26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3201\/eid3001.230427","article-title":"Costs of digital adherence technologies for tuberculosis treatment support, 2018\u20132021","volume":"30","author":"Nsengiyumva","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"2026021701300540000_22.1.250173.27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/tropicalmed7050065","article-title":"Time trend analysis of tuberculosis treatment while using digital adherence technologies\u2014an individual patient data meta-analysis of eleven projects across ten high tuberculosis-burden countries","volume":"7","author":"de Groot","year":"2022","journal-title":"Trop Med Infect Dis"}],"container-title":["Breathe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/20734735.0173-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T09:30:18Z","timestamp":1771320618000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/20734735.0173-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1183\/20734735.0173-2025"],"URL":"https:\/\/doi.org\/10.1183\/20734735.0173-2025","relation":{},"ISSN":["1810-6838","2073-4735"],"issn-type":[{"value":"1810-6838","type":"print"},{"value":"2073-4735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}